These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36975215)

  • 1. Joint contribution of MC1R and MITF alleles to melanoma risk in the age of polygenic risk scores.
    Bruno W
    Br J Dermatol; 2023 May; 188(6):696-697. PubMed ID: 36975215
    [No Abstract]   [Full Text] [Related]  

  • 2. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
    Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
    Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
    Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
    Berwick M; MacArthur J; Orlow I; Kanetsky P; Begg CB; Luo L; Reiner A; Sharma A; Armstrong BK; Kricker A; Cust AE; Marrett LD; Gruber SB; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Venn A; Busam K; From L; White K; Thomas NE;
    Pigment Cell Melanoma Res; 2014 May; 27(3):485-8. PubMed ID: 24406078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A germline oncogenic MITF mutation and tumor susceptibility.
    Paillerets BB; Lesueur F; Bertolotto C
    Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary. A picture of Mitf in melanoma immortality.
    Goding CR
    Oncogene; 2011 May; 30(20):2304-6. PubMed ID: 21278792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intronic variants of MITF (rs7623610) and CREB1 (rs10932201) genes may enhance splicing efficiency in human melanoma cell line.
    Carron J; Torricelli C; Silva JK; Coser LO; Lima CSP; Lourenço GJ
    Mutat Res; 2021; 823():111763. PubMed ID: 34710701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation.
    Bassoli S; Pellegrini C; Longo C; Di Nardo L; Farnetani F; Cesinaro AM; Pellacani G; Fargnoli MC
    Melanoma Res; 2018 Apr; 28(2):166-169. PubMed ID: 29485552
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer risks associated with the germline MITF(E318K) variant.
    Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
    Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of MITF on melanoma development: news from bench and bedside.
    Roider EM; Fisher DE
    J Invest Dermatol; 2014 Jan; 134(1):16-17. PubMed ID: 24352080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lack of E318K MITF germline mutation in Latvian melanoma patients.
    Ozola A; Pjanova D
    Cancer Genet; 2015 Jun; 208(6):355-6. PubMed ID: 25975176
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
    Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
    J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
    Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin Pigmentation Genetics for the Clinic.
    Ainger SA; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    Dermatology; 2017; 233(1):1-15. PubMed ID: 28463841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent mutations in the MITF pathway in melanoma.
    Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an amplified transcription factor in melanoma.
    Cancer Biol Ther; 2005 Aug; 4(8):iv-v. PubMed ID: 16710937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.